AIKI stock forecast
Our latest prediction for AIkido Pharma Inc's stock price was made on the April 22, 2021 when the stock price was at 0.92$.
In the short term (2weeks), AIKI's stock price should outperform the market by 5.17%. During that period the price should oscillate between -10.83% and +23.44%.
In the medium term (3months), AIKI's stock price should outperform the market by 15.87%. During that period the price should oscillate between -42.86% and +65.78%.Get email alerts
Create a solid portfolio with AIKI
About AIkido Pharma Inc
AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.44$ per share.
The book value per share is 0.33$
Three months stock forecastApril 22, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|